Concepedia

Author

Paul F. Pollack

Abbott Fund

Also Known As

PAUL F. POLLACK, Paul F Pollack, Paul F. Pollack

60

Publications

5.9K

Citations

24

H-Index

49

Concepts

All Affiliations

Abbott FundCentre Hospitalier Universitaire de LilleUniversity of California San DiegoHôpital Claude HuriezAbbVie (United States)
PF

About

Paul F. Pollack is an author at Abbott Fund specializing in medicine, gastroenterology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

3.9K

2

Public Health

2

2

64

3

Allergy

1

1

10

4

Anesthesia

1

1

81

5

Emergency Medicine

1

1

81

Paul F. Pollack

×

29

Publications

5.8K

Citations

23

H-Index

YearCitations

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts,

Gastroenterology

2006

2.2K

Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

William J. Sandborn, Paul Rutgeerts, Robert Enns,

Annals of Internal Medicine

2007

955

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Paul Rutgeerts, Gert Van Assche, William J. Sandborn,

Gastroenterology

2012

575

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

Jean‐Frédéric Colombel, Paul Rutgeerts, William J. Sandborn,

Clinical Gastroenterology and Hepatology

2013

245

Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial

Edward V. Loftus, Brian G. Feagan, Jean‐Frédéric Colombel,

The American Journal of Gastroenterology

2008

210

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel,

Gastroenterology

2013

189

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś,

Gastroenterology

2021

143

Necrotizing enterocolitis in term infants

Richard A. Polin, Paul F. Pollack, Barbara Barlow,

The Journal of Pediatrics

1976

130

Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease

Yi‐Lin Chiu, David T. Rubin, Séverine Vermeire,

Inflammatory Bowel Diseases

2013

122

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE

Robert Löfberg, Edouard V. Louis, Walter Reinisch,

Inflammatory Bowel Diseases

2011

118

Page 1